Inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strength.
The microgravity conditions of prolonged spaceflight are known to result in skeletal muscle atrophy that leads to diminished functional performance. To assess if inhibition of the growth factor myostatin has potential to reverse these effects, mice were treated with a myostatin antibody while housed...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0230818 |
id |
doaj-decc66a177f0408f8026fd6a168de5b9 |
---|---|
record_format |
Article |
spelling |
doaj-decc66a177f0408f8026fd6a168de5b92021-03-03T21:39:06ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01154e023081810.1371/journal.pone.0230818Inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strength.Rosamund C SmithMartin S CramerPamela J MitchellJonathan LucchesiAlicia M OrtegaEric W LivingstonDarryl BallardLing ZhangJeff HansonKenneth BartonShawn BerensKelly M CredilleTed A BatemanVirginia L FergusonYanfei L MaLouis S StodieckThe microgravity conditions of prolonged spaceflight are known to result in skeletal muscle atrophy that leads to diminished functional performance. To assess if inhibition of the growth factor myostatin has potential to reverse these effects, mice were treated with a myostatin antibody while housed on the International Space Station. Grip strength of ground control mice increased 3.1% compared to baseline values over the 6 weeks of the study, whereas grip strength measured for the first time in space showed flight animals to be -7.8% decreased in strength compared to baseline values. Control mice in space exhibited, compared to ground-based controls, a smaller increase in DEXA-measured muscle mass (+3.9% vs +5.6% respectively) although the difference was not significant. All individual flight limb muscles analyzed (except for the EDL) weighed significantly less than their ground counterparts at the study end (range -4.4% to -28.4%). Treatment with myostatin antibody YN41 was able to prevent many of these space-induced muscle changes. YN41 was able to block the reduction in muscle grip strength caused by spaceflight and was able to significantly increase the weight of all muscles of flight mice (apart from the EDL). Muscles of YN41-treated flight mice weighed as much as muscles from Ground IgG mice, with the exception of the soleus, demonstrating the ability to prevent spaceflight-induced atrophy. Muscle gene expression analysis demonstrated significant effects of microgravity and myostatin inhibition on many genes. Gamt and Actc1 gene expression was modulated by microgravity and YN41 in opposing directions. Myostatin inhibition did not overcome the significant reduction of microgravity on femoral BMD nor did it increase femoral or vertebral BMD in ground control mice. In summary, myostatin inhibition may be an effective countermeasure to detrimental consequences of skeletal muscle under microgravity conditions.https://doi.org/10.1371/journal.pone.0230818 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rosamund C Smith Martin S Cramer Pamela J Mitchell Jonathan Lucchesi Alicia M Ortega Eric W Livingston Darryl Ballard Ling Zhang Jeff Hanson Kenneth Barton Shawn Berens Kelly M Credille Ted A Bateman Virginia L Ferguson Yanfei L Ma Louis S Stodieck |
spellingShingle |
Rosamund C Smith Martin S Cramer Pamela J Mitchell Jonathan Lucchesi Alicia M Ortega Eric W Livingston Darryl Ballard Ling Zhang Jeff Hanson Kenneth Barton Shawn Berens Kelly M Credille Ted A Bateman Virginia L Ferguson Yanfei L Ma Louis S Stodieck Inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strength. PLoS ONE |
author_facet |
Rosamund C Smith Martin S Cramer Pamela J Mitchell Jonathan Lucchesi Alicia M Ortega Eric W Livingston Darryl Ballard Ling Zhang Jeff Hanson Kenneth Barton Shawn Berens Kelly M Credille Ted A Bateman Virginia L Ferguson Yanfei L Ma Louis S Stodieck |
author_sort |
Rosamund C Smith |
title |
Inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strength. |
title_short |
Inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strength. |
title_full |
Inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strength. |
title_fullStr |
Inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strength. |
title_full_unstemmed |
Inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strength. |
title_sort |
inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strength. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2020-01-01 |
description |
The microgravity conditions of prolonged spaceflight are known to result in skeletal muscle atrophy that leads to diminished functional performance. To assess if inhibition of the growth factor myostatin has potential to reverse these effects, mice were treated with a myostatin antibody while housed on the International Space Station. Grip strength of ground control mice increased 3.1% compared to baseline values over the 6 weeks of the study, whereas grip strength measured for the first time in space showed flight animals to be -7.8% decreased in strength compared to baseline values. Control mice in space exhibited, compared to ground-based controls, a smaller increase in DEXA-measured muscle mass (+3.9% vs +5.6% respectively) although the difference was not significant. All individual flight limb muscles analyzed (except for the EDL) weighed significantly less than their ground counterparts at the study end (range -4.4% to -28.4%). Treatment with myostatin antibody YN41 was able to prevent many of these space-induced muscle changes. YN41 was able to block the reduction in muscle grip strength caused by spaceflight and was able to significantly increase the weight of all muscles of flight mice (apart from the EDL). Muscles of YN41-treated flight mice weighed as much as muscles from Ground IgG mice, with the exception of the soleus, demonstrating the ability to prevent spaceflight-induced atrophy. Muscle gene expression analysis demonstrated significant effects of microgravity and myostatin inhibition on many genes. Gamt and Actc1 gene expression was modulated by microgravity and YN41 in opposing directions. Myostatin inhibition did not overcome the significant reduction of microgravity on femoral BMD nor did it increase femoral or vertebral BMD in ground control mice. In summary, myostatin inhibition may be an effective countermeasure to detrimental consequences of skeletal muscle under microgravity conditions. |
url |
https://doi.org/10.1371/journal.pone.0230818 |
work_keys_str_mv |
AT rosamundcsmith inhibitionofmyostatinpreventsmicrogravityinducedlossofskeletalmusclemassandstrength AT martinscramer inhibitionofmyostatinpreventsmicrogravityinducedlossofskeletalmusclemassandstrength AT pamelajmitchell inhibitionofmyostatinpreventsmicrogravityinducedlossofskeletalmusclemassandstrength AT jonathanlucchesi inhibitionofmyostatinpreventsmicrogravityinducedlossofskeletalmusclemassandstrength AT aliciamortega inhibitionofmyostatinpreventsmicrogravityinducedlossofskeletalmusclemassandstrength AT ericwlivingston inhibitionofmyostatinpreventsmicrogravityinducedlossofskeletalmusclemassandstrength AT darrylballard inhibitionofmyostatinpreventsmicrogravityinducedlossofskeletalmusclemassandstrength AT lingzhang inhibitionofmyostatinpreventsmicrogravityinducedlossofskeletalmusclemassandstrength AT jeffhanson inhibitionofmyostatinpreventsmicrogravityinducedlossofskeletalmusclemassandstrength AT kennethbarton inhibitionofmyostatinpreventsmicrogravityinducedlossofskeletalmusclemassandstrength AT shawnberens inhibitionofmyostatinpreventsmicrogravityinducedlossofskeletalmusclemassandstrength AT kellymcredille inhibitionofmyostatinpreventsmicrogravityinducedlossofskeletalmusclemassandstrength AT tedabateman inhibitionofmyostatinpreventsmicrogravityinducedlossofskeletalmusclemassandstrength AT virginialferguson inhibitionofmyostatinpreventsmicrogravityinducedlossofskeletalmusclemassandstrength AT yanfeilma inhibitionofmyostatinpreventsmicrogravityinducedlossofskeletalmusclemassandstrength AT louissstodieck inhibitionofmyostatinpreventsmicrogravityinducedlossofskeletalmusclemassandstrength |
_version_ |
1714815943728693248 |